Dr. Nicholas B. Countryman, MD

Dr. Countryman practices at Dawes Fretzin Dermatology Group in Indianapolis, Indiana.

Dr. Countryman's NPI, 1538327309, was assigned on May 29, 2008. Dr. Countryman graduated from Yale School of Medicine in 2005. Dr. Countryman's Indiana license number on file is 01069284A.

Dr. Countryman's primary practice is Dawes Fretzin Dermatology Group, at 7910 N Shadeland Ave, Indianapolis, IN 46250 in Marion County. The practice phone is (317) 516-5000.

Dr. Countryman's primary practice is Dawes Fretzin Dermatology Group in Indianapolis, Indiana. The medical group on file is Dawes Fretzin Dermatology. Dmand AI also links Dr. Countryman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Countryman practices. Vendor and product names are available with a free account.

Dermatology is Dr. Countryman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Countryman is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Countryman's licenses on file in 3 states: Indiana, Washington and North Carolina.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes and skin discoloration among the conditions Dr. Countryman treats.

CMS data shows 2,432 Medicare services from Dr. Countryman across 36 procedure codes in 2024, for 749 Medicare patients. Medicare paid $621,081 for them. Every service was in an office.

CMS counts 749 Medicare patients who saw Dr. Countryman in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Countryman's median patient age at 76, with 44% women.

In 2024, Dr. Countryman wrote 527 Medicare Part D claims for 337 patients. 100% of them were for generic drugs. CMS names the drug for 480 of them, across 7 drugs with 11 or more claims each, at $3,627 in total drug cost. In 2023, CMS named 444 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Countryman for performance year 2024, reported as part of a group. Dr. Countryman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 220 procedures of melanoma (skin cancer) excision by Dr. Countryman, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Countryman, published from 2011 to 2013. 2011 was the busiest year, with 2. The most frequent topics are Mohs Surgery, Skin Neoplasms and Head and Neck Neoplasms. Dr. Countryman has published most often in Dermatol Surg. Dr. Countryman's most frequent co-authors are Carl William Hanke, MD and Barry Leshin, MD.

CMS Open Payments shows 254 general payments to Dr. Countryman from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,092.

Dr. Countryman graduated from Yale School of Medicine in 2005.

Dr. Countryman is in network with 15 carriers, including Elevance, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.